Skip to main content
Transforming Care and Inspiring Hope for all children...

Researchers Release Results from Clinical Trial for Treatment of Primary Ciliary Dyskinesia

September 12, 2023
A phase 2 study, led by Thomas W. Ferkol, MD, at the UNC School of Medicine, demonstrates safety and efficacy of idrevloride with hypertonic saline for treatment of primary ciliary dyskinesia, a rare genetic disorder that can lead to permanent lung damage.

Orr NIH Award on Childhood Food Insecurity and Obesity

July 31, 2023
Dr. Colin Orr, Assistant Professor of Pediatrics in General Pediatrics & Adolescent Medicine, received a K23 Career Development Award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a part of the United States National Institutes of Health. Dr. Orr's funded project is titled “Understanding and Addressing...

Improving the Lives of Children with Cystic Fibrosis

July 31, 2023
Investigators in Pediatric Pulmonology at UNC Children’s are playing key roles in the study and treatment of Cystic Fibrosis (CF). According to the Cystic Fibrosis Foundation, the current life expectancy for CF patients born between 2017 and 2021 is 53 years — a substantial change from just 10 years ago...

Multi-year Renewal for the UNC-Kinshasa School of Public Health Research Partnership in the DRC

July 30, 2023
Dr. Melissa Bauserman, Associate Professor of Pediatrics in Neonatal-Perinatal Medicine, and her team recently received notice of renewal for the funding in support of the University of North Carolina-Kinshasa School of Public Health Research Partnership in the Democratic Republic of Congo; a Model for Improving Women's and Children's Health Through...

Researchers Announce Findings from Landmark Clinical Trial for Pediatric Crohn’s Disease

April 3, 2023
Michael Kappelman, MD, MPH, was the lead PI on the clinical trial, which followed nearly 300 children with Crohn’s to evaluate how their conditions changed in response to anti-TNF biologic treatments alone or in combination with a second immune suppressive medication.

Novel Peanut Allergy Treatment Shown to be Safe, Effective, and Lasting

February 27, 2023
A four-year clinical trial led by Edwin Kim, MD, at the UNC School of Medicine, has found that an increased dosage of a unique type of peanut allergy immunotherapy continues to show promise for children.

Single Dose of Azithromycin Reduces Maternal Sepsis or Death

February 9, 2023
A UAB-UNC School of Medicine collaboration found that a single oral dose of the common antibiotic azithromycin reduced the risk of maternal sepsis or death by 33 percent in women who delivered vaginally. UNC School of Medicine study leads were Melissa Bauserman, MD, MPH, Carl Bose, MD, and Jackie Patterson,...

Ian Davis Awarded $1 Million by V Foundation

January 17, 2023
The V Foundation Board of Directors and Scientific Advisory Board has awarded funding to Ian Davis, MD, PhD, the G. Denman Hammond Professor of Childhood Cancer in the Division of Hematology/Oncology and a UNC Lineberger Comprehensive Cancer Center member, for his research project, “Novel mechanisms to improve CAR-T cell therapy...

UNC Researchers Tackle the E-cigarette or Vaping Product Use–associated Lung Injury (EVALI) Epidemic

January 5, 2023
Meghan Rebuli, PhD, Assistant Professor of Pediatrics in the Division of Allergy-Immunology and member of the Center for Environmental Medicine, Asthma, and Lung Biology, shares new findings and recommendations from an expert-led workshop.

Good Awarded $1 Million by CZI to Combat NEC

December 1, 2022
Principal investigators Misty Good, MD, MS, and Scott Magness, PhD, at the UNC School of Medicine, and Jennifer Canvasser, MSW, NEC Society will lead a $1-million project funded through the Chan Zuckerberg Initiative to map cellular roles in necrotizing enterocolitis (NEC).